s6y
Company name or ticker
Search
Orexigen Therapeutics, Inc.
4
Cannell Thomas R: Change in insider ownership
Filed
Friday, June 2, 2017
Period
May 31, 2017
Accession number
0001209191-17-037271
Documents
Change in insider ownership
4
Certifications, consents and other formalities
1
Poa Document
24.4_728643
Poa Document
EX-24.4_728643
On sec.gov
Filing index
All files
Complete submission text
SGML header